Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Clinical trial NCT02303184 · COMPLETED
Trial details
- NCT number
- NCT02303184
- Sponsor
- Clearside Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.